Dallas,TX (PRWEB) January 08, 2015
One of the major trends upcoming in this market is the automation of gene expression profiling. This helps reduce consumption of reagents, and enhances accuracy and productivity in research and drug discovery.
According to the report, one of the major drivers of the market is advances in the gene expression market. As a result of automation, accuracy, and sensitivity of gene expression, technology and products have improved. Advanced gene expression products such as DNA microarray chips, RT-PCR, and advanced NGS provide a high degree of accuracy, efficiency, and productivity in research and drug discovery.
Further, the report states that one of the major challenges in the market is intense competition among vendors. Numerous large and medium-scale companies in the market provide high-end gene expression products, including instruments and software.
Order a copy of this report at (Prices start at US $ 3000 for a single user PDF) http://www.reportsnreports.com/Purchase.aspx?name=322429 .
Key players in the Global Gene Expression Market are Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Qiagen NV and Thermo Fisher Scientific Inc.
Other Prominent Vendors in the market are Agena Bioscience, Applied Microarrays, Arrayit, AutoGenomics, BD, Beijing Genomics Institute, BioChain Institute, Biometrix Technology, Cepheid, CombiMatrix, Danaher, Danyel Biotech (a Part of Gamida for Life Group), EMD Millipore, Eppendorf, Exiqon, Fluidigm, GE Healthcare, Great Basin, LC Sciences, Luminex, Microarrays, Miltenyi Biotec, OriGene Technologies, Oxford Gene Technology, Oxford Nanopore Technologies, Partek, Perkin Elmer, Phalanx Biotech Group, Promega, Takara Bio, Tecan, Veredus Laboratories and Zyagen.